Grand Medical

Focus: Grand Medical is a biotechnology company headquartered in Israel specializing in medical monitoring and interface products across oncology, infectious diseases, neurology, metabolic, and respiratory indications. The company operates with 8 active job openings and maintains a diverse pipeline spanning early-stage to late-stage development programs.

Oncology Infectious Diseases Neurology Metabolic Diseases

Profile data last refreshed 17h ago · AI intelligence enriched 1w ago

Open Jobs

Should You Work at Grand Medical?

AI assessment

Grand Medical is a niche, early-stage biotech with broad pipeline ambition but limited hiring and uncertain financial footing—suitable only for risk-tolerant candidates seeking exposure to medical device–pharma intersection.

Why Work Here

Exposure to diverse therapeutic areas (5 major indications) with pipeline depth across Phase 1–4, providing broad clinical and development experience.

Data completeness

2/9 — Limited

Company HealthStrong

Pipeline

Mid-stage

2 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

CST Intervention

Dementia

N/A

Clinical Trials (1)

NCT02229474IDEA Study Cognitive Stimulation Therapy (CST) Trial in Tanzania

N/A

Help build intelligence for Grand Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Medical device/monitoring interface focus offers differentiation from traditional small-molecule or biologic-only biotech companies.

Israeli biotech hub location provides access to strong technical talent pool and innovation ecosystem.

Watch Out For

Extremely small active job count (8 roles) signals limited hiring capacity and career mobility within the organization.
Highly heterogeneous pipeline (30 programs spanning observational studies, repurposed drugs, devices, and novel therapeutics) suggests unfocused strategy and unclear lead program validation.
Complete absence of financial data (revenue, funding, cash position, R&D spend) creates visibility gap on company stability and runway.

Generated by Claude from Grand Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Real World Stage II-III NSCLC Patients Receiving Neoadjuvant Chemo-immunotherapy and no Surgical Res

Stage II-III Non-small Cell Lung Cancer

N/A

Clinical Trials (1)

NCT07131163Real World Stage II-III NSCLC Patients Receiving Neoadjuvant Chemo-immunotherapy and no Surgical Resection

N/A

Risk Assessment, Counselling & Resources

Preconception Care

N/A

Clinical Trials (1)

NCT02746601My Health eSnapshot - A Preconception Health Research Study

N/A

Brief Intervention in Public Clinic

Alcohol-Related Disorders

N/A

Clinical Trials (1)

NCT02388243The Computer-based Drug and Alcohol Training Assessment in Kenya

N/A

Administration of the EUonQoL-Kit - Active Treatment questionnaire

Cancer

N/A

Clinical Trials (1)

NCT05947903Validation of the European Oncology Quality of Life Toolkit

N/A

TREATAPROST

Quality of Life

N/A

Clinical Trials (1)

NCT05306314Retrospective Chart Review of Treataprost Added to Antibiotic Treatment in Patients With Chronic Prostatitis

N/A

ALK Digital Pathology Outcome Predition, Multi Institutional, Restrospective Study

Alk-positive Non-Small Cell Lung Cancer

N/A

Clinical Trials (1)

NCT06846736ALK Digital Pathology Outcome Predition, Multi Institutional, Restrospective Study

N/A

CST intervention

Dementia

N/A

Clinical Trials (1)

NCT02233530IDEA Study Cognitive Stimulation Therapy (CST) Trial in Nigeria

N/A

Quantified Evaluation of Noninvasive System Delivering Microwave Energy for Unwanted Fat Reduction a

Facial Aging

N/A

Clinical Trials (1)

NCT06925074Quantified Evaluation of Noninvasive System Delivering Microwave Energy for Unwanted Fat Reduction and Skin Tightening in Asians.

N/A

Observational study

Vaginal Neoplasms

N/A

Clinical Trials (1)

NCT06514235Image-guided Brachytherapy for Vaginal Cancer (EMBRAVE)

N/A

Early Weight Bearing Tarsometatarsal Fusion Study

Hallux Valgus

N/A

Clinical Trials (1)

NCT03812237Early Weight Bearing Tarsometatarsal Fusion Study

N/A

3D MRI-guided Brachytherapy

Cervical Cancer

N/A

Clinical Trials (1)

NCT00920920An International Study on Magnetic Resonance Imaging (MRI)-Guided Brachytherapy in Locally Advanced Cervical Cancer

N/A

Histolog Scanner

Breast Cancer

N/A

Clinical Trials (1)

NCT04976556Breast Cancer Detection in Breast Surgical Specimens With the Histolog Scanner, Slide-free Confocal Microscope

N/A

Observational

Hip Fracture

N/A

Clinical Trials (1)

NCT02804542Fascia Iliaca Blocks and Pre-operative Opioid Requirements in Hip Fracture Patients

N/A

CASITA

Child Developmental Delay

N/A

Clinical Trials (1)

NCT03010306CASITA Intervention for Children at Risk of Delay in Carabayllo, Peru

N/A

Cervical cancer screening

Uterine Cervical Neoplasms

N/A

Clinical Trials (1)

NCT01968837The Kilimanjaro Cervical Screening Project

N/A

Community emotional intelligence network

Mental Health Conditions

N/A

Clinical Trials (1)

NCT06968403Community Emotional Intelligence Network to Address Mental Health Among Coastal Bangladeshis

N/A

No intervention

Neoplasms

N/A

Clinical Trials (1)

NCT04746729Health Effects of CArdiac FluoRoscopy and MOderN RadIotherapy in PediatriCs - Radiotherapy

N/A

HZBio1 0.96mg / kg

Healthy Participants

Phase 1

Clinical Trials (1)

NCT04765995Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of of HZBio1 in Healthy Subjects

Phase 1

CHERL

Tobacco Use Disorder

Phase 1

Clinical Trials (1)

NCT00269009CHERL, Connecting Primary Care Patients With Community Resources to Facilitate Behavior Change

Phase 1

STC314 injection or Placebo

Acute Respiratory Distress Syndrome

Phase 1

Clinical Trials (1)

NCT05000671A Study to Evaluate the Safety and Effect of STC314 Injection Continuous Infusion in Subjects With Acute Respiratory Distress Syndrome

Phase 1

Tampostat

Postpartum Hemorrhage

Phase 1/2

Clinical Trials (1)

NCT02416089Tampostat for Management of Postpartum Hemorrhage

Phase 1/2

ch14.18/CHO

Neuroblastoma

Phase 1/2

Clinical Trials (1)

NCT01701479Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2)

Phase 1/2

Vaginal brachytherapy

Endometrial Cancer

Phase 2

Clinical Trials (1)

NCT05640999Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Phase 2

STC3141

Severe COVID-19 Pneumonia

Phase 2

Clinical Trials (1)

NCT04880694A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia

Phase 2

STC314 Injection/STC314 Injection Placebo

Sepsis

Phase 2

Clinical Trials (1)

NCT06548854A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Dose Exploration Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Characteristics of STC314 Injection Administered Intravenously in Sepsis Patients

Phase 2

TVAX-008

HBV Infection

Phase 2

Clinical Trials (1)

NCT07179653A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Chronic Hepatitis B Patients

Phase 2

Increased use of IC/IS technique in BT

Uterine Cervical Neoplasms

Phase 2

Clinical Trials (1)

NCT03617133Image Guided IMRT, Radiochemotherapy and MRI-based IGABT in Locally Advanced Cervical Cancer

Phase 2

Temozolomide/Hycamtin

Neuroblastoma

Phase 2

Clinical Trials (1)

NCT00918320Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid Tumours

Phase 2

Statins

Intracerebral Hemorrhage

Phase 3

Clinical Trials (1)

NCT03936361Statins In Intracerbral Hemorrhage

Phase 3

Nivolumab

Metastatic Kidney Cancer

Phase 3

Clinical Trials (1)

NCT06364631CARE1 Pragmatic Clinical Trial

Phase 3

Bifidobacterium tetrad live bacteria tablet plus Helicobacter pylori quadruple eradication therapy

Helicobacter Pylori Eradication

Phase 4

Clinical Trials (1)

NCT04034641Effect of Probiotics on Helicobacter Pylori Eradication

Phase 4

Dexmedetomidine

Sepsis

Phase 4

Clinical Trials (1)

NCT01760967Dexmedetomidine for Sepsis in ICU Randomized Evaluation Trial

Phase 4

Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live

Type 2 Diabetes Mellitus With Complication

Phase 4

Clinical Trials (1)

NCT04982380Efficacy and Safety of Bifidobacterium Quadruple Live Tablets in Patients With T2DM and Constipation

Phase 4

Interview Prep Quick Facts

Portfolio: 34 clinical trials

Top TAs: Oncology, Infectious Diseases, Neurology

Open Roles: 8 active jobs

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

13 pipeline

3 pipeline

2 pipeline

1 pipeline

1 pipeline

Marketed

Pipeline

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Grand Medical

Should You Work at Grand Medical?

Why Work Here

Pipeline & Clinical Trials

Watch Out For

Open Jobs (8)

Senior 2D Artist

Senior Animator

Growth Manager

Game Developer

Senior 3D Marketing Artist

Senior 3D Artist

Product Manager - Level & Gameplay

Senior Product Manager

Hiring Trend